معرفی
Rachel Katz, MD, is an Assistant Professor of Psychiatry at Yale School of Medicine and Co-Director of the Transcranial Magnetic Stimulation (TMS) Service. She specializes in interventional psychiatry and mood disorders, focusing on advanced treatments like TMS and ketamine therapy for depression and anxiety. Her clinical roles include Chief Resident and Fellow positions at Yale New Haven Hospital.
Education:
- BS in Religion, Communication Sciences, and Dance (Northwestern University, 2008)
- MD (Case Western Reserve University School of Medicine, 2013)
Research Interests:
Dr. Katz’s work centers on neuromodulation techniques (TMS/ECT), late-life psychiatric disorders, and optimizing non-pharmacological interventions. She collaborates with researchers like Gerard Sanacora and John Krystal on ketamine and ECT efficacy.
Publications:
Her recent work compares ketamine and ECT for depression (2025), explores ECT safety in complex cases (2024), and advocates for interventional psychiatry in clinical practice (2022).
Awards:
Includes the Distinguished Women in Medicine Award (2020), Ira Levine Award (2015), and Alpha Omega Alpha honor society (2013).
Service & Activities:
She serves on the International Society for Electroconvulsive Therapy and Neuromodulation Education Committee, edits the Case Western Reserve Psychiatry E-Journal, and reviews for Nature and Journal of ECT.
